Prostate cancer and its treatment are associated with many long-term adverse effects including cancer-related cognitive impairment. Specifically, androgen deprivation therapy has been shown to negatively impact cognitive function. Combined aerobic and resistance training has been shown to improve cognitive function in men treated with androgen deprivation therapy, but limited research has observed its impact into survivorship. Additionally, existing study designs are limited to supervised, combined aerobic and resistance training interventions. Remotely-delivered resistance training programs could enhance exercise participation by overcoming commonly reported barriers in men living with and beyond prostate cancer such as transportation, distance to facility, and timing of programs. Alongside the needs to address cancer-related cognitive impairments due to androgen deprivation therapy, resistance training may serve to manage functional deficits, losses in bone mineral density and muscle mass and increases in cardiometabolic risk factors. This study will assess the feasibility of an 8-week remotely-delivered resistance training program to improve cognitive function in men living with and beyond prostate cancer who have a history of androgen deprivation therapy treatment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Enrollment
Timeframe: Change from baseline (pre- intervention) to post-intervention (8 weeks).
Adherence
Timeframe: Change from baseline (pre- intervention) to post-intervention (8 weeks).
Attrition
Timeframe: Change from baseline (pre- intervention) to post-intervention (8 weeks).
Adverse Events
Timeframe: Change from baseline (pre- intervention) to post-intervention (8 weeks).
Participant Satisfaction
Timeframe: Post-intervention (8 weeks).
Therapeutic Alliance
Timeframe: Post-intervention (8 weeks).